🟢 Decoy Therapeutics is trading 5.7% up today on an extended rebound from its Ebola Zaire platform success

Decoy Therapeutics is trading at $4.26 (+5.71%) in after-hours trading, extending a rebound tied to the success of its Ebola Zaire platform.

• The move follows July 28 lab results that previously sparked a sharp rally, as investors continue to react to the company's antiviral platform update.
• The stock is outperforming a weak broader market currently weighed down by the Fed holding rates steady and increased geopolitical tensions.
• Shares remain volatile in thin extended-hours trading, reflecting a clear company-specific catalyst despite lower liquidity.